Repligen (RGEN) Tops Q1 EPS by 10c ; Offers Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $176.89 -0.73%
Revenue Growth %: +9.4%
Financial Fact:
Product revenue: 24.68M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +9.4%
Financial Fact:
Product revenue: 24.68M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.48, $0.10 better than the analyst estimate of $0.38. Revenue for the quarter came in at $194 million versus the consensus estimate of $192.05 million.
GUIDANCE:
Repligen sees FY2026 EPS of $1.97-$2.05, versus the consensus of $1.97.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- OpenAI's Sam Altman to brief the UN Security Council next week - Reuters
- RBC Capital Reiterates Sector Perform Rating on Freehold Royalties Ltd. (FRU:CN) (FRHLF)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
